Methods of using dantrolene to treat nerve agent exposure
- 专利权人:
- Inc.;Eagle Pharmaceuticals
- 发明人:
- HEPNER, Adrian
- 申请号:
- AU2018328131
- 公开号:
- AU2018328131A1
- 申请日:
- 2018.09.05
- 申请国别(地区):
- AU
- 年份:
- 2020
- 代理人:
- 摘要:
- The disclosure is directed to methods of treating subjects exposed to nerve agents with dantrolene, or a pharmaceutically acceptable salt thereof.
- 来源网站:
- 中国工程科技知识中心